Granules India Limited, a vertically integrated, rapidly growing Indian pharmaceutical company, announced that the FDA has approved its Abbreviated New Drug Application (ANDA) for metoprolol succinate extended-release tablets USP, 25 mg, 50 mg, 100..
TR Life Sciences a hospital management consulting firm has noted that because of the booming growth, many Indian hospital entrepreneurs are wanting to spread their wings to other countries. They intend to leverage their strengths in global markets,..
In a $3.5 billion transaction, Novartis will acquire US-based Chinook Therapeutics, a clinical-stage biopharmaceutical business. Upon reaching specific regulatory milestones, Chinook common investors will earn $3.2 billion and $0.3 billion in cash...
A current Active Pharmaceutical Ingredient (API) production plant in Denmark will be expanded as part of Novo Nordisk's announced plans to invest 15.9 billion Danish kroner beginning in 2023 for the company's future portfolio of major chronic...
In addition to being a prospective market with strong growth, Bayer Pharma sees India as a hub for innovation, R&D, and potential partnerships, according to the company's top executives.
Contract manufacturing and development organizations (CMOs and CDMOs) have many potentials in the expanding field of personalized medicine.
It is not surprising to see wearable technology entering the pharmaceutical industry given how prevalent it has become in the sports and fitness industry.
The agreement was launched by AliveCor India Pvt. Ltd., the leading inventor in FDA-cleared personal electrocardiogram (ECG) technology, and Vieroots Wellness Solutions Pvt Ltd, a health-tech start-up focused to giving personalised solutions to...
TS LOHMANN Therapie-Systems AG (LTS), a leading pharmaceutical technology company, has completed the acquisition of Eitan Medical Ltd's (Eitan Medical) Sorrel Wearable Injection Devices (Sorrel' business in Netanya, Israel...
Amarna Therapeutics, a privately held biotechnology company, has named Dr Henk Streefkerk as its new chief executive officer and medical director. He takes over for Steen Klysner, who has been CEO for the past three years. Since mid-2022,...
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")
